EBMT 2019 | CAR T-cell therapy: what clinicians need to know about managing the AEs

David Maloney

From the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany, David Maloney, MD, PhD, of Fred Hutchinson Cancer Research Center, Seattle, WA, talks about the adverse events associated with CAR T-cell therapy and what clinicians need to be aware of.

Share this video  
Similar topics